AI
Biogen to collaborate with Envisagenics on RNA splicing research
May 14, 2021Medical Communications AI
Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …
Exscientia launch trial of third AI-designed molecule
May 13, 2021AI, Altzeimer's, Exscientia
Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …
Facio Therapies announces AI collaboration for FSHD drug design
May 11, 2021Manufacturing and Production AI, drug discovery
Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …
Scipher Medicine to expand into autoimmune disease therapeutics
April 30, 2021Medical Communications AI, autoimmune diseases
Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …
Exscientia enter first-ever AI cancer drug into Phase I trials
April 9, 2021Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news
Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …
Iktos and Pfizer collaborate on AI drug design
March 2, 2021Manufacturing and Production AI, Iktos, Pfizer
Iktos has announced that its artificial intelligence (AI) technology for de novo design will be applied to selected Pfizer small-molecule …
AstraZeneca reaches deal with RenalytixAI to develop medicine strategies for a variety of diseases
August 24, 2020Sales and Marketing AI, chronic disease
AstraZeneca and RenalytixAI have agreed a deal to develop joint precision medicine strategies for cardiovascular, renal and metabolic diseases. The …
Yale-backed study to test efficacy of AI-selected therapy in COVID-19
July 28, 2020Manufacturing and Production, Research and Development AI, COVID-19, clinical trial, pharma
Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …
New research outlines guidelines for the ethical use of AI in healthcare
May 20, 2020Research and Development AI, coronavirus
A new study published in The Lancet has called on the global health community to establish guidelines to develop and …
New antibiotic discovered by AI for the first time
February 21, 2020Medical Communications AI, AI Clinical Trials, AI Drugs, AI antibiotics, MIT, algorithm, clinical trials
MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …
FDA approves Caption Health’s AI-guided imaging system
February 10, 2020Sales and Marketing AI, Caption Health, FDA, ultrasound, ultrasound imaging
The FDA have given marketing approval for Caption Health’s Caption Guidance and its use in cardiac ultrasound images.The technology allows …
How AI is making clinical trials more accurate and affordable
February 5, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials
Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …
Exscientia creates first drug using AI
January 31, 2020Medical Communications AI, AI healthcare, ai pharma
Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge …
AI is more accurate than doctors at diagnosing breast cancer, study finds
January 2, 2020Business Services AI, AI Cancer, AI Trials, AI diagnoses, AI in clinical trials, Cancer, breast cancer
A recent study showed that Artificial Intelligence is more accurate than doctors in diagnosing breast cancer from mammograms. The research …
Few in NHS trust tech firms handling patient data
November 29, 2019Medical Communications AI, Boris, Corbyn, NHS, NHS Brexit, johnson
Few in the NHS trust ‘big tech’ companies to handle patient data in a confidential manner, a recent YouGov poll …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
